10x Genomics Commercially Launches Xenium Platform for In Situ Analysis

/PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a life sciences leader focused on mastering biology to advance human health, today announced the first...

Related Keywords

,Nicholas Banovich ,Ben Hindson ,Bill Flynn ,Exchange Commission ,Tgen Center ,Genomics Inc ,Translational Genomics Research Institute Tgen ,Genomics Inc Nasdaq ,Securities Exchange ,Jackson Laboratory For Genomic Medicine ,Xenium Analyzer ,Xenium Explorer ,Chief Scientific Officer ,Xenium Platform ,Associate Director ,Single Cell Biology ,Jackson Laboratory ,Single Cell ,Spatial Multiomics ,Associate Professor ,Translational Genomics Research Institute ,Private Securities Litigation Reform Act ,Securities Act ,Securities Exchange Act ,Financial Condition ,10x Genomics ,Nc ,